Elisabeth Leiderman insider trades

Open-market stock purchases and sales by Elisabeth Leiderman, Director at Autolus Therapeutics plc, from SEC Form 4 filings since Oct 15, 2021.

Recent trades

DateStockTradeValue
Jun 29, 2026AUTL Autolus Therapeutics plcBought (not open market)—
Jun 29, 2026AUTL Autolus Therapeutics plcBought (not open market)—

Companies traded

  • AUTL Autolus Therapeutics plc: other filings, last Jun 29, 2026
  • BLUE bluebird bio, Inc: 1 sale, last Jun 2, 2025
  • DBTX Decibel Therapeutics, Inc: other filings, last Feb 25, 2022

Get free alerts when Elisabeth Leiderman files a new trade →